Clinical Trial

Pharmacokinetics and Placental Transfer of Caffeine

Study acronym: AnteCaff
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this study is to learn how a pregnant person's body processes caffeine and how much caffeine crosses the placenta to the baby. A small dose of caffeine will be given to each pregnant participant before delivery. Blood will be drawn to measure caffeine levels in the pregnant mother. Blood will also be taken from the placenta and from the newborn to measure caffeine levels. This data will be used to form a computer model of the metabolism of caffeine during pregnancy.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-06-05
notable Primary completion pushed: 2027-03 -> 2027-06 2026-06-05
Trial Details
NCT Number NCT07570121
Lead Sponsor Indiana University
Collaborators: Indiana Clinical and Translational Sciences Institute
Conditions Preterm Labor With Preterm Delivery, Premature Birth, Apnea of Prematurity, Respiratory Distress Syndrome, Bronchopulmonary Dysplasia
Enrollment 30 participants
Start Date 2026-06-01
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-04